ArticlePloS one2025
Higher red cell distribution width (RDW) is associated with increased all-cause and cardiovascular mortality in patients with breast cancer: A retrospective analysis of NHANES data (1999-2018).
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Red Cell Distribution Width to Red Blood Cell Ratio: A Novel Biomarker for Predicting 30-Day Mortality in Type B Acute Aortic Dissection.Emergency medicine international · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe correlation between red cell distribution width (RDW) and mortality in breast cancer participants is not well-defined. This study investigates the association between RDW and both all-cause and cardiovascular mortality in the US population.
methodsA retrospective cohort study was performed using data from 15,806 participants in the NHANES dataset. Multivariable Cox regression models were used to analyze demographic, socioeconomic, clinical, and laboratory factors, with adjustments for potential confounders. Restricted cubic spline (RCS) analysis was utilized to investigate the non-linear associations between RDW and mortality outcomes, and Kaplan-Meier (KM) survival curves were created to illustrate RDW's effect on survival rates. Subgroup analyses and time-dependent ROC curves were also utilized to further assess the predictive value of RDW across different time intervals and patient subgroups.
resultsElevated RDW significantly correlates with a heightened risk of all-cause mortality (adjusted HR 2.13, 95% CI 1.42-3.20) and cardiovascular mortality (adjusted HR 3.94, 95% CI 1.71-9.09) compared to lower RDW in Model 3. The association remained consistent across subgroups, with no significant interaction effects (p > 0.05). The RCS analysis demonstrated a positive linear relationship between RDW and mortality outcomes. Additionally, Kaplan-Meier analysis indicated that individuals with elevated RDW levels exhibited significantly lower survival rates. Time-dependent ROC and AUC analyses demonstrated that RDW was a more robust predictor of short-term mortality, as evidenced by higher AUC values in the initial years following diagnosis.
conclusionsRed cell distribution width (RDW) serves as an independent predictor of both all-cause and cardiovascular mortality in breast cancer patients, showing strong predictive power for outcomes in both the short and long term.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.